For example, in colorectal cancer, tumor growth and niche inflammation are both attenuated by the dual inhibition of IGF-1R signaling and the STAT3 pathway, resulting in much smaller tumor sizes in both primary and metastatic tumors (Sanchez-Lopez et al., 2016). This evidence concerns the gene IGF1R and colorectal cancer.